Molecular Events for Promotion of Vancomycin Resistance in Vancomycin Intermediate Staphylococcus aureus

Area of Science:

• Microbiology
• Genetics
• Molecular Biology

Background:

• Vancomycin is a critical last-resort antibiotic for serious Staphylococcus aureus infections.
• Vancomycin-intermediate S. aureus (VISA) strains present a significant clinical challenge, characterized by thickened cell walls, reduced autolysis, and attenuated virulence.
• The genetic underpinnings of VISA phenotypes are diverse and not fully elucidated.

Approach:

• Comparative genomics of vancomycin-susceptible S. aureus (VSSA) and VISA pairs identified numerous genetic mutations.
• Focused review and analysis of genetic alterations in key determinants, including vraTSR, graSR, walKR, stk1/stp1, rpoB, clpP, and cmk genes.
• Investigated the mechanisms by which diverse mutations confer vancomycin resistance.

Key Points:

• VISA strains share common phenotypic characteristics (e.g., cell wall thickening) despite heterogeneous genetic mutations.
• Mutations in genes such as vraTSR, graSR, and walKR are frequently associated with VISA.
• Experimental verification of identified mutations is crucial for understanding resistance mechanisms.

Conclusions:

• Diverse genetic mutations converge to produce common vancomycin resistance phenotypes in S. aureus.
• A unified model is proposed to integrate the complex genetic and biochemical processes underlying VISA.
• Further research is needed to experimentally validate identified mutations and refine the proposed model.